Hutri-Kähönen N, Kähönen M, Jolma P, Wu X, Sand J, Nordback I, Ylitalo P, Arvola P, Pörsti I
Medical School, Department of Pharmacological Sciences, University of Tampere, Finland.
Naunyn Schmiedebergs Arch Pharmacol. 1999 Apr;359(4):322-30. doi: 10.1007/pl00005358.
The majority of the findings concerning arterial physiology and pathophysiology originate from studies with experimental animals, while only limited information exists about the functional characteristics of human arteries. Therefore, the aim of the present work was to compare the control of vascular tone in vitro in mesenteric arterial rings of corresponding size (outer diameter 0.75-1 mm) from humans and Wistar-Kyoto rats. The relaxations to acetylcholine (ACh) were clearly less marked in the mesenteric arteries of humans when compared with rats. However, when calcium ionophore A23187 was used as the vasodilator, the endothelium-mediated relaxations did not significantly differ between these species. The NO synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) attenuated the relaxations to ACh and A23187 in both groups. The endothelium-independent relaxations to the beta-adrenoceptor agonist isoprenaline and the nitric oxide (NO)-donor nitroprusside were somewhat lower in human arteries, while vasodilation induced by the K+ channel opener cromakalim was similar between humans and rats. Arterial contractile sensitivity to noradrenaline and serotonin was slightly lower in human vessels, whereas contractile sensitivity to KCl was similar between these species. The contractions induced by cumulative addition of Ca2+ with noradrenaline as the agonist were effectively inhibited in both groups by the calcium channel blocker nifedipine, the effect of which was clearly more pronounced in human arteries. In conclusion, the control of vascular tone of isolated arteries of corresponding size from humans and rats appeared to be rather similar. The most marked differences between these species were the impaired endothelium-mediated dilation to ACh and the more pronounced effect of nifedipine on the Ca2(+)-induced contractions in human arteries.
大多数关于动脉生理和病理生理的研究结果都来自对实验动物的研究,而关于人类动脉功能特性的信息却非常有限。因此,本研究的目的是比较人类和Wistar-Kyoto大鼠相应大小(外径0.75-1毫米)的肠系膜动脉环在体外的血管张力控制情况。与大鼠相比,人类肠系膜动脉对乙酰胆碱(ACh)的舒张反应明显较弱。然而,当使用钙离子载体A23187作为血管扩张剂时,这些物种之间内皮介导的舒张反应没有显著差异。一氧化氮合酶抑制剂N(G)-硝基-L-精氨酸甲酯(L-NAME)减弱了两组对ACh和A23187的舒张反应。人类动脉对β-肾上腺素能受体激动剂异丙肾上腺素和一氧化氮(NO)供体硝普钠的非内皮依赖性舒张反应略低,而钾通道开放剂克罗卡林诱导的血管舒张在人类和大鼠之间相似。人类血管对去甲肾上腺素和5-羟色胺的动脉收缩敏感性略低,而对氯化钾的收缩敏感性在这些物种之间相似。以去甲肾上腺素为激动剂,通过累积添加Ca2+诱导的收缩在两组中均被钙通道阻滞剂硝苯地平有效抑制,其作用在人类动脉中明显更显著。总之,人类和大鼠相应大小的离体动脉的血管张力控制似乎相当相似。这些物种之间最显著的差异是内皮介导的对ACh的舒张受损以及硝苯地平对人类动脉中Ca2+诱导的收缩的更显著作用。